Many times, whistle-blowers come forward and thats the end of their career, she said. Add to that Trumps prospective optimism about HCQ as a potential game-changer, and you can see plenty enough reason for all of these not-so-scientific studies and even more breathless media reports denouncing a treatment that, in its best protocol, has shown itself to be better than 90 percent effective in beating the virus. Who is Joe LaCava? Former GOP House SpeakerRead More, For two years, the Democrats have insisted that, on Jan.Read More, You know by now that Pennsylvania's junior senator, in everyRead More, Although Ive occasionally run across Scott Adams long-running comic strip,Read More, The look on the face of communist revolutionary and blackRead More, Until a couple of decades ago, voting in the UnitedRead More, Example: Yes, I would like to receive emails from The American Spectator | USA News and Politics. One day they wake up and realize they've become their parents. Dr. Rick Bright, a top infectious disease expert within the Department of Health and Human Services (HHS), will testify Thursday morning about his removal from a senior post overseeing pandemic preparedness after he resisted efforts to distribute an unproven drug that had been promoted by the Trump administration and warned about scarcity of medical supplies. This created a single point failure for the entire National Pandemic Plan. Late last year, at a panel discussion on the future of influenza pandemics, Bright explained his fundamental concerns: the country was not investing enough in creating vaccines that could potentially limit the impact of the annual flu season as well as potential pandemics. In other words, this is a war. What, do you know him? Bright, for his part, has made it clear that he has no intention of shuffling off to some lesser job at the National Institutes of Health without a fight. "HHS leadership was dismissive about my dire predictions about what I assumed would be a broader outbreak and the pressing need to act, and were therefore unwilling to act with the urgency that the situation required," Bright is expected to say, according to a prepared copy of his remarks released Wednesday. He then worked at Yerkes National Primate Research Center after his college completion in the department of Immunology and Microbiology and also in the Vaccine Research Center from 1997 to 2000. After Dr.
Since his whistleblower complaint went public, Bright has been open about his concerns regarding the U.S.s pandemic preparedness and its focus on promoting chloroquine and hydroxychloroquine as drugs to treat COVID-19.